(Q43505317)

24 November 2017

title

Therapeutic evaluation of free and nanocapsule-encapsulated atovaquone in the treatment of murine visceral leishmaniasis (English)

1 reference

24 November 2017

main subject

visceral leishmaniasis

1 reference

E Cauchetier

1

1 reference

24 November 2017

M Paul

2

1 reference

24 November 2017

D Rivollet

3

1 reference

24 November 2017

H Fessi

4

1 reference

24 November 2017

A Astier

5

1 reference

24 November 2017

M Deniau

6

1 reference

24 November 2017

publication date

1 April 2003

1 reference

Annals of Tropical Medicine and Parasitology

24 November 2017

published in

1 reference

24 November 2017

volume

97

1 reference

24 November 2017

issue

3

1 reference

24 November 2017

page(s)

259-268

1 reference

Biochemical mechanisms of the antileishmanial activity of sodium stibogluconate

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2F000349803235001840

Atovaquone-loaded nanocapsules: influence of the nature of the polymer on their in vitro characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349803235001840

Recent advances in liposomal drug-delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349803235001840

The activity of hydroxynaphthoquinones against Leishmania donovani

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349803235001840

Lipid membrane structure and interactions in dimethyl sulfoxide/water mixtures

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349803235001840

Influence of different physicochemical conditions on the release of indium oxine from nanocapsules

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349803235001840

U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349803235001840

Assessment of the activity of atovaquone-loaded nanocapsules in the treatment of acute and chronic murine toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349803235001840

In vitro study of the anti-leishmanial activity of biodegradable nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349803235001840

Activity of pentamidine-loaded poly (D,L-lactide) nanoparticles against Leishmania infantum in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349803235001840

Therapeutic evaluation of free and liposome-encapsulated atovaquone in the treatment of murine leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349803235001840

Flow cytometric assessment of amphotericin B susceptibility in Leishmania infantum isolates from patients with visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349803235001840

Activity of pentamidine-loaded methacrylate nanoparticles against Leishmania infantum in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349803235001840

Design of new formulations for topical ocular administration: polymeric nanocapsules containing metipranolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349803235001840

Entrapment efficiency and initial release of phenylbutazone from nanocapsules prepared from different polyesters

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349803235001840

Visceral leishmaniasis in HIV infected patients: treatment with high dose liposomal amphotericin B (AmBisome)

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349803235001840

Anin vitrorelease kinetic examination and comparative evaluation between submicron emulsion and polylactic acid nanocapsules of clofibride

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349803235001840

The experimental chemotherapy of leishmaniasis, IV. The development of a rodent model for visceral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349803235001840

10.1179/000349803235001840

21 January 2018

Identifiers

DOI

1 reference

24 November 2017

1 reference